11. 重症筋無力症 Myasthenia gravis Clinical trials / Disease details

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

12 trials found

diseases per page:

Showing 1 to 10 of 12 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCT2031220102	28/10/2022	31/05/2022	A Study of Nipocalimab in Children Aged 2 to less than 18 Years with Generalized Myasthenia Gravis	An Open-Label Uncontrolled Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Saf ...	Myasthenia Gravis	Nipocalimabwill be administered as an IV infusion. Participants aged 2 to less than [<] 18 years of a ...	Nakano Masayoshi	NULL	Pending	>= 2age old	<= 17age old	Both	12	Phase 2	Canada;Netherlands;nitedStates of America;Japan
2	NCT05265273 (ClinicalTrials.gov)	July 20, 2022	22/2/2022	A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis	An Open-Label Uncontrolled Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Saf ...	Myasthenia Gravis	Drug: Nipocalimab	Janssen Research & Development, LLC	NULL	Recruiting	2 Years	17 Years	All	12	Phase 2/Phase 3	United States;Canada;Japan;Netherlands;Poland
3	JPRN-jRCT2021210027	20/01/2022	13/08/2021	A Study of Nipocalimab Administered to Adults with Generalized Myasthenia Gravis	Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, S ...	Myasthenia Gravis	Nipocalimab(JNJ-80202135, M281) Double-blind Placebo-controlled Phase: Participants will receive nipo ...	Nakano Masayoshi	NULL	Pending	>= 18age old	Not applicable	Both	180	Phase 3	Belgium;Canada;China;Colombia;Czechia;Germany;Denmark;Spain;France;Kingdom Of Great Britain And Nort ...
4	EUCTR2020-005732-29-DK (EUCTR)	13/01/2022	25/06/2021	Efficacy and Safety Study of Nipocalimab IV Infusions for Adults With Generalized Myasthenia Gravis	Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, S ...	Myasthenia gravis (MG). MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myasthenia ...	Product Name: Nipocalimab Product Code: JNJ-80202135 INN or Proposed INN: Nipocalimab Other descriptive ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	105	Phase 3	United States;Czechia;Taiwan;Spain;Turkey;Russian Federation;Colombia;United Kingdom;Italy;France;Cz ...
5	EUCTR2020-005732-29-PL (EUCTR)	10/12/2021	24/06/2021	Efficacy and Safety Study of Nipocalimab IV Infusions for Adults With Generalized Myasthenia Gravis	Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, S ...	Myasthenia gravis (MG). MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myasthenia ...	Product Name: Nipocalimab Product Code: JNJ-80202135 INN or Proposed INN: Nipocalimab Other descriptive ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	United States;Czechia;Taiwan;Spain;Turkey;Russian Federation;Colombia;United Kingdom;Italy;France;Cz ...
6	EUCTR2020-005732-29-DE (EUCTR)	19/11/2021	23/06/2021	Efficacy and Safety Study of Nipocalimab IV Infusions for Adults With Generalized Myasthenia Gravis	Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, S ...	Myasthenia gravis (MG). MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myasthenia ...	Product Name: Nipocalimab Product Code: JNJ-80202135 INN or Proposed INN: Nipocalimab Other descriptive ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	105	Phase 3	United States;Czechia;Taiwan;Spain;Turkey;Russian Federation;Colombia;United Kingdom;Italy;France;Cz ...
7	EUCTR2020-005732-29-SE (EUCTR)	03/11/2021	24/06/2021	Efficacy and Safety Study of Nipocalimab IV Infusions for Adults With Generalized Myasthenia Gravis	Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, S ...	Myasthenia gravis (MG). MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myasthenia ...	Product Name: Nipocalimab Product Code: JNJ-80202135 INN or Proposed INN: Nipocalimab Other descriptive ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	105	Phase 3	United States;Czechia;Taiwan;Spain;Turkey;Russian Federation;Colombia;United Kingdom;Italy;France;Cz ...
8	EUCTR2020-005732-29-CZ (EUCTR)	21/10/2021	15/07/2021	Efficacy and Safety Study of Nipocalimab IV Infusions for Adults With Generalized Myasthenia Gravis	Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, S ...	Myasthenia gravis (MG). MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myasthenia ...	Product Name: Nipocalimab Product Code: JNJ-80202135 INN or Proposed INN: Nipocalimab Other descriptive ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	United States;Czechia;Taiwan;Spain;Turkey;Russian Federation;Colombia;United Kingdom;Italy;France;Cz ...
9	EUCTR2020-005732-29-ES (EUCTR)	03/09/2021	26/08/2021	Efficacy and Safety Study of Nipocalimab IV Infusions for Adults With Generalized Myasthenia Gravis	Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, S ...	Myasthenia gravis (MG). MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myasthenia ...	Product Name: Nipocalimab Product Code: JNJ-80202135 INN or Proposed INN: Nipocalimab Other descriptive ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	105	Phase 3	United States;Czechia;Taiwan;Spain;Turkey;Russian Federation;Colombia;United Kingdom;Italy;France;Hu ...
10	EUCTR2020-005732-29-IT (EUCTR)	20/08/2021	12/10/2021	Efficacy and Safety Study of Nipocalimab IV Infusions for Adults With Generalized Myasthenia Gravis	Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, S ...	Myasthenia gravis (MG);Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]	Product Name: Nipocalimab Product Code: [JNJ-80202135] INN or Proposed INN: Nipocalimab Other descripti ...	JANSSEN CILAG INTERNATIONAL NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	105	Phase 3	United States;Czechia;Taiwan;Spain;Turkey;Russian Federation;Colombia;United Kingdom;Italy;France;Cz ...

First Previous1 2Next Last